Healthcare & Life Sciences
ReveraGen
About
ReveraGen is developing an anti-inflammatory treatment for Duchenne muscular dystrophy with fewer side effects than current glucocorticoids.
Explore ReveraGen's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.